Список литературы

1. Epstein A.E., Bigger J.T., Wyse D.S. et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled. - J Am Coll Cardiol - 1991 - 18 - p. 14 - 19.

2. Gallavardin L. Extraststolic ventriqular a paroxysmes tachycardiques prolonges. - Arch Mal Coeur Vaiss - 1922 - v. 15 - p. 298 - 306.

3. Apshtein A.E., Ideker R.E. Ventricular Fibrillation in "Cardiac Electrophysiology. From Cell to Bedside", ed. By Zipes D.P. and Jalife J., W.B.Saunders Company - 2000 - p. 677 - 684.

4. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. - Circulation - 2006. - v. 114 - p. e385 - e484.

5. Priori SG, , Mazzanti A et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology. - Eur Heart J. - 2015. - 36(41). - p. 2793 - 867.

6. Нестеренко Л.Ю., Ковешникова М.Н., Бакалов С.А. и соавт. Факторы, определяющие эффективность длительной антиаритмической терапии при жизнеугрожающих желудочковых аритмиях. - Фарматека. - 2005. - N 8. - с. 41.

7. Bayes de Luna A., Coumel P., Leclercq J. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. - Am. Heart J - 1989 - v. 117 - p. 151 - 159.

8. Bigger J.T. Identification of patients at high risk for sudden cardiac death. - Am J Cardiol. - 1984 - v. 54 - 14 - p. 3D - 8D.

9. Yancy CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA Guidelines for the Management of Heart Failure. - Circulation. - 2013. - v. 128 (16). - e240 - 327.

10. Epstein AE, Dimarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities - Circulation - 2008 - v. 117 - p. e450 - e408.

11. Priori S.G., Wilde A.A., Horie M et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013 Dec; 10(12): 1932 - 63.

12. Schwartz P.J., Stramba-Badiale M., Crotti L. et al., Prevalence of the congenital long-QT syndrome. Circulation. - 2009. - 120(18). - p. 1761 - 7.

13. Crotti L., Celano G., Dagradi F. et al. Congenital long QT syndrome. Orphanet J Rare Diseases. - 2008. - 3:18.

14. Curran M.E., Splawski I., Timothy K.W. et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long-QT syndrome. - Cell. - 1995. - 80. - p. 795 - 803.

15. Chen Q., Kirsch G.E., Zhang D. et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. - Nature. - 1998. - 392. - p. 293 - 296.

16. Ackerman M.J., Priori S.G., Willems S. et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). - Heart Rhythm. - 2011. - 8(8). - p. 1308 - 39.

17. Vincent G.M., Schwartz P.J., Denjoy I. et al. High efficacy of betablockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of betablocker treatment "failures". - Circulation. - 2009. - 119(2). - p. 215 - 21.

18. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. - J Am Coll Cardiol. - 1992. - 20. - p. 1391 - 1396.

19. Antzelevitch C., Brugada P., Borggrefe M. et al. Brugada syndrome: report of the second consensus conference. - Heart Rhythm. - 2005. - 2(4). - p. 429 - 40.

20. Di Diego J.M., Cordeiro J.M., Goodrow R.J. et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. - Circulation. - 2002. - 106(15). - p. 2004 - 11.

21. Shimizu W., Matsuo K., Kokubo Y. et al. Sex hormone and gender difference-role of testosterone on male predominance in Brugada syndrome. - J Cardiovasc Electrophysiol. - 2007. - 18(4). - p. 415 - 21.

22. Obeyesekere M.N., Klein G.J., Modi S. et al. How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia. - Circ Arrhythm Electrophysiol. - 2011. - 4(6). - p. 958 - 64.

23. Postema P.G., Wolpert C., Amin A.S. et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). - Heart Rhythm. - 2009. - 6(9). - p. 1335 - 41.

24. Marquez M.F., Bonny A., Hernandez-Castillo E. et al. Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. Heart Rhythm. - 2012. - 9(12). - p. 1995 - 2000.

25. Leenhardt A., Lucet V., Denjoy I. et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. - Circulation. - 1995. - 91(5). - p. 1512 - 19.

26. Priori S.G., Napolitano C., Memmi M. et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. - Circulation. - 2002. - 106. - p. 69 - 74.

27. Gussak I., Brugada P., Brugada J. et al. Idiopathic short QT interval: a new clinical syndrome? - Cardiology. - 2000. - 94. - p. 99 - 102.

28. Gaita F., Giustetto C., Bianchi F. et al. Short QT syndrome: a familial cause of sudden death. - Circulation. - 2003. - 108. - p. 965 - 70.

29. Fontaine G.H. The multiple facets of right ventricular cardiomyopathies. - Eur Heart J. - 2011. - 32(9). - p. 1049 - 51.

30. Corrado D., Buja G., Basso C. et al. Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy. - J of Electrocardiol. - 2000. - 33. - p. 49 - 55.

31. Theine G., Nava A., Corrado D. et al. Right ventricular cardiomyopathy and sudden death in young people. - N Engl J Med. - 1988. - 318. - p. 129 - 33.

32. Carvajal-Huerta L. Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol. - 1998. - 39(3). - p. 418 - 21.

33. Marcus F., Towbin J., Zareba W. et al. Arrhythmogenic right ventricular dysplasia/cardiomiopathy (ARVD/C). A multidisciplinary study: design and protocol. - Circulation. - 2003. - 107. - p. 2975 - 78.

34. Dewilde W., Boersma L., Delanote J. et al. Symptomatic arrhythmogenic right ventricular dysplasia/cardiomyopathy. A twocentre retrospective study of 15 symptomatic ARVD/C cases and focus on the diagnostic value of MRI in symptomatic ARVD/C patients. - Acta Cardiol. - 2008. - 63(2). - 181 - 89.

35. Marcus F.I., McKenna W.J., Sherrill D. et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. - Circulation. - 2010. - 121. - p. 1533 - 41.

36. Ki s P., Bootsma M., Bax J. et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. - Heart Rhythm. - 2006. - 3(2). - p. 225 - 34.

37. Pelliccia A., Corrado D., Bjornstad H.H. et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. - Eur. J. Cardiovasc. Prev. Rehab. - 2006. - 13. - p. 876 - 85.

38. Basso C., Corrado D., Marcus F.I. et al. Arrhythmogenic right ventricular cardiomyopathy. - The Lancet. - 2009. - 373. - p. 1289 - 1300.

39. Голицын С.П., Бакалов С.А., Нестеренко Л.Ю. Аритмогенная дисплазия правого желудочка: современные подходы к диагностике и лечению. - Сердце. - 2005. - N 4. - с. 197.

40. Wichter T., Paul T.M., Eckardt L. et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? - Herz. - 2005. - 30. - p. 91 - 101.

41. Marcus G.M., Glidden D.V., Polonsky B. et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: A report from the North American ARVC registry. - J Am Coll Cardiol. - 2009. - 54. - p. 609 - 15.

42. Arbelo E., Josephson M.E. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia. - J Cardiovasc Electrophysiol. - 2010. - 21. - p. 473 - 86.